Insider selling
Traded Nov 5 · filed 1 day laterNot reported under a pre-arranged trading plan
A Bristol Myers Squibb director sold $241K of Bristol Myers Squibb shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
New
Compared with the manager's Q2 2026 13F
77,808
0.02%
Within the filing's reported positions, not the manager's total assets
1
For Q3 2026
Insider selling
Traded Nov 5 · filed 1 day laterNot reported under a pre-arranged trading plan
A Bristol Myers Squibb director sold $241K of Bristol Myers Squibb shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 5 · filed the same day
A Bristol Myers Squibb director told the SEC about a plan to sell $250K of Bristol Myers Squibb shares around Nov 5, 2026. The shares were not acquired as compensation.
Insider filing
Traded Nov 3 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.